Progress of researches on albendazole for treatment of alveolar echinococcosis].

Alveolar echinococcosis, caused by Echinococcus multilocularis infection, is a highly deadly zoonotic parasitic disease. As a benzimidazole compound, albendazole has a strong and broad-spectrum anti-parasitic action. For alveolar echinococcosis patients that are unwilling to receive surgical treatment, lose the timing for surgery, or are intolerant to surgery due to poor physical status, administration of albendazole may delay disease progression. Recently, a large number of advances have been achieved in experimental studies on alveolar echinococcosis. In order to increase the understanding of the therapeutic efficacy of albendazole for alveolar echinococcosis, this review summarizes the advances in albendazole treatment for alveolar echinococcosis, so as to provide insights into the clinical treatment of alveolar echinococcosis with albendazole.

Citation

Z Cui, G Ye, W Yu, Z Wang, F Kong, L Ren. Progress of researches on albendazole for treatment of alveolar echinococcosis]. Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control. 2022 Aug 30;35(1):104-110

Mesh Tags

Substances

PMID: 36974024

search → result